CCR2 and ductal breast carcinoma in situ: In the hDCIS.01 and primary DCIS cases examined in the MIND models, CCR2 expression was associated with increased growth and invasion of breast lesions and increased phospho-p42/44MAPK and phospho-SMAD3 expression.